APA (7th ed.) Citation

Alabi, B., Lawal, S. K., Olojede, S. O., Suleiman, A., Adesanya, O., Ochuole, D. O., . . . Ben-Azu, B. (2025). In silico and in vivo toxicity assessment of cysteamine-modified nanoparticles: Implications for pharmacotherapy application. Toxicology Mechanisms & Methods, 35(9), 1400. https://doi.org/10.1080/15376516.2025.2538128

Chicago Style (17th ed.) Citation

Alabi, Babatunde, Sodiq Kolawole Lawal, Samuel Oluwaseun Olojede, Amina Suleiman, Olamide Adesanya, Diana Odey Ochuole, Fisayo Nathaniel Ogunleye, and Benneth Ben-Azu. "In Silico and in Vivo Toxicity Assessment of Cysteamine-modified Nanoparticles: Implications for Pharmacotherapy Application." Toxicology Mechanisms & Methods 35, no. 9 (2025): 1400. https://doi.org/10.1080/15376516.2025.2538128.

MLA (9th ed.) Citation

Alabi, Babatunde, et al. "In Silico and in Vivo Toxicity Assessment of Cysteamine-modified Nanoparticles: Implications for Pharmacotherapy Application." Toxicology Mechanisms & Methods, vol. 35, no. 9, 2025, p. 1400, https://doi.org/10.1080/15376516.2025.2538128.